Where there is knowledge, there is also hope.

What is Prolaris?

A cancer diagnosis can be scary. Your imagination might be working overtime, playing out best and worst-case scenarios. It’s normal. There’s so much to learn about which treatment is right for you, and it can be unsettling not to know how this will all shake out.

Prolaris is a genetic test for untreated men with prostate cancer that can determine how quickly the cancer is growing.

Prolaris helps provide clarity about your cancer’s behavior, so you can make informed decisions about your treatment with confidence.

Is the test right for me?

Any patient diagnosed with localized prostate cancer is a candidate for Prolaris testing. There is no need to undergo any additional biopsies since all patients with prostate cancer have already received a prostate biopsy.

Learn how genetic testing can determine the best prostate cancer treatment for you.

Benefits of waiting: none
Benefits of testing: immeasurable

Why Take The Test?

The Prolaris test adds clinically-proven, objective information to subjective diagnostic tools like PSA and Gleason. It gives you clear answers to some of your most pressing questions, like how aggressive is my prostate cancer?

Benefits of Prolaris:

  • Identifies your chance of dying from prostate cancer
  • Know your chance of cancer spreading into other areas of your body
  • Confidence to choose active surveillance or active treatment

How does Prolaris work?

Our test carefully assesses your unique risk factors and provides objective information about how aggressive your cancer is. The results tell you if you’re safe to avoid treatment and actively keep watch, or if it makes sense to pursue surgery or radiation. Prolaris gives your doctor the information needed to create a personalized treatment plan. And it gives you a sense of relief that comes from knowing what to expect.

It starts with you!

Be proactive and request the test from your doctor.

View our guide on:
Tips for Talking to Your
Healthcare Provider
About Prolaris

Doctor approves the test order.

After the test is ordered, Myriad will obtain the necessary cancer tissue from an existing biopsy.

Your genes are analyzed at our state-of-the-art facility.

Myriad looks at your unique genetic information using the latest in sequencing.

Results are available in around 2 weeks.

Once results are available, they are sent securely to your doctor’s office. Your doctor will help you understand the results so you can own your health.

Easy-to-understand results

After a prostate cancer diagnosis, choosing an appropriate treatment path can be incredibly stressful for you and your loved ones. Further complicating the problem is that unlike many other forms of cancer, there are several ways that Prostate cancer can be treated.

The Prolaris test results come with a patient-friendly summary page designed to help you clearly and confidently understand which treatment pathway is right for you.

Men with Prostate cancer that is not considered to be aggressive, may be safely monitored using Active Surveillance. While it is normal to feel some unease with choosing to just watch your cancer, Active Surveillance is the recommended management option for most men with lower risk cancers.

Men with more aggressive tumors should undergo treatment. The type and intensity of the treatment are usually tailored to the potential risk of the disease. Single-modal therapy means one form of treatment is recommended. The most common forms of treatment include surgical removal of the prostate, radiation therapy, and hormonal therapy.

Men with very aggressive cancer may be offered multi-modal therapy, which employs two or more therapies planned at the onset of treatment. National cancer guidelines offer treatment option suggestions based on the patient’s risk and potential treatment outcomes.

Active Surveillance

Men with Prostate cancer that is not considered to be aggressive, may be safely monitored using Active Surveillance. While it is normal to feel some unease with choosing to just watch your cancer, Active Surveillance is the recommended management option for most men with lower risk cancers.

Single-Modal Treatment

Men with more aggressive tumors should undergo treatment. The type and intensity of the treatment are usually tailored to the potential risk of the disease. Single-modal therapy means one form of treatment is recommended. The most common forms of treatment include surgical removal of the prostate, radiation therapy, and hormonal therapy.

Multi-Modal Treatment

Men with very aggressive cancer may be offered multi-modal therapy, which employs two or more therapies planned at the onset of treatment. National cancer guidelines offer treatment option suggestions based on the patient’s risk and potential treatment outcomes.

Better answers are here now. Schedule a no-cost and confidential appointment with a Myriad Genetics advisor to learn more about genetic testing for prostate cancer and how it could benefit you.

How much does it cost?

97% of people have coverage for genetic testing, with 93% of all patients paying $0.

For those with an out-of-pocket cost – the average is < $60.

We’re with you every step of the way.

Because patients and their families use test results to make life-saving medical decisions. Myriad is committed to providing patients with access to accurate and affordable genetic results.

Insurance Coverage

Myriad is in-network with most major insurance plans including Medicare. For commercial and government-funded plans, Myriad will work with your health insurance company to obtain coverage for the test ordered by your healthcare provider.

“Without information how can you make treatment decisions?”

– Byron Sparkman

See how Prolaris helped Byron take control of his prostate cancer.  

“It had affected my family as much as it had affected just me.”

– Ed Hoppe

See how genetic testing helped empower Ed Hoppe and change his treatment decisions.  

“Cancer has always kind of been in the family somewhere.”

– Ellen Hoppe

After Ed’s diagnosis, his daughter, Ellen, decided to take the myRisk Hereditary Cancer test. Watch her story.  

The Myriad advantage

7 million patients tested

Committed to making testing easy and affordable

Committed to keeping your genetic privacy safe

Lifetime commitment to helping you understand your results and disease

Don’t Wait! Be proactive with Prolaris.

You deserve better answers about your prostate cancer. There’s no benefit in waiting for your doctor to suggest Prolaris, but there are big benefits to taking the test now. Be proactive and request our patient guide today.

OR

Contact a Myriad trusted advisor at 513-216-4752